An MIT spin-off company called Sherlock Biosciences has gotten FDA approval to begin using its CRISPR-based COVID-19 test, which promises to be faster and easy to perform without access to a full lab.

Researchers are racing to develop quick, home-based tests for the virus that could deliver test results in minutes. None do that yet, but several... CRISPR And Spit Might Be Keys To Faster, Cheaper, ...

Most public health experts agree that widespread testing will be needed to bring the COVID-19 pandemic under control. But for now, most coronavirus tests require specialized laboratories and high-tech ...

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.